	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S84-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S84-BMJ_2010_Apr_29_340_c1640	['we could not examine the Vitamin D status of the fetus directly but INSTEAD chose the ambient ultraviolet radiation level experienced by the mother during Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'gestation')]
S101-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S101-BMJ_2010_Apr_29_340_c1640	['for example, Vitamin D can down-regulate Interleukin 6, an IMPORTANT mediator of the adverse EFFECT of maternal infection during Pregnancy on neural development in the fetus.505152\n\nPrenatal and Postnatal timing\nour results do not INDICATE that the POSSIBLE beneficial EFFECT of Ultraviolet radiation exposure is confined ONLY to the Prenatal period.']	[('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000008988', 'interleukin-1 family member 5', 41, 'interleukin 6'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'Prenatal'), ('GO_0007567', 'parturition', 195, 'postnatal'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 279, 'ultraviolet'), ('GO_0007565', 'female pregnancy', 334, 'prenatal')]
S500-PMC2679409	PMC2679409	5/2009	S500-PMC2679409	['ANY FUTURE STUDIES of Vitamin A supplementation MUST FOCUS on HIGH-RISK women, assess the most APPROPRIATE Vitamin type and dosage, and show that the intervention is both SAFE for the mother and fetus, and EFFECTIVE.']	[('IMPORTANT_CONSIDERATION', 0), ('FUTURE_WORK', 4), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 62), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 171), ('SUPERFICIAL_RELATIONSHIP', 206)]	8	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
S20-PMC2821652	PMC2821652	2/2010	S20-PMC2821652	['with respect to the more Polar Metabolites of Vitamin D, a SIMILAR (BUT lesser) RELATIONSHIP is OBSERVED between mother and fetus [11].']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 96)]	5	[('CHEBI_37173', 'silanol', 25, 'polar'), ('CHEBI_25212', 'metabolite', 31, 'metabolites'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S22-PMC2821652	PMC2821652	2/2010	S22-PMC2821652	['this lack of Placental transfer of the parent Vitamin D from mother to fetus also HAS BEEN observed in a Porcine experimental Animal MODEL [13].']	[('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 133)]	2	[('UBERON_0001987', 'placenta', 13, 'placental'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'porcine'), ('NCBITaxon_33208', 'Metazoa', 126, 'animal')]
S23-PMC2821652	PMC2821652	2/2010	S23-PMC2821652	['THUS, in the Human fetus, Vitamin D Metabolism in all LIKELIHOOD begins with 25(Oh)D. as a result, the nutritional Vitamin D status of the Human fetus/neonate is totally DEPENDENT on the Vitamin D stores of the mother [11]; THUS, IF the mother is hypovitaminotic D, her fetus will experience depleted Vitamin D exposure throughout Gestation [14].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 170), ('PROBABLE_UNDERSTANDING', 224), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230)]	5	[('NCBITaxon_9606', 'Homo sapiens', 13, 'human'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 26, 'vitamin D metabolism'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 331, 'gestation')]
S24-PMC2821652	PMC2821652	2/2010	S24-PMC2821652	['WHILE the demands of the fetus on the maternal System for calcium increase throughout Pregnancy, the demands for Vitamin D DO NOT APPEAR TO change.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 123), ('ANOMALY_CURIOUS_FINDING', 130)]	3	[('UBERON_0000467', 'anatomical system', 47, 'system'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
S147-PMC3004407	PMC3004407	12/2010	S147-PMC3004407	['this is concerning in that the EFFECTS of Vitamin D deficiency among Pregnancy women are not limited to the women: IF a mother has Vitamin D insufficiency, or worse, deficiency, her fetus is developing in a hypovitaminotic state.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
S158-PMC3004407	PMC3004407	12/2010	S158-PMC3004407	['studies TO EXAMINE the BENEFIT of higher doses of Vitamin D during Pregnancy SUGGEST that the dose of Vitamin D FOUND in MOST Prenatal Vitamins—400\u2009iu—is INADEQUATE to meet the NEEDS of the Pregnant woman and her growing fetus [11,32,34,39,60–67].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 121), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 177)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 135, 'vitamins'), ('GO_0007565', 'female pregnancy', 190, 'pregnant')]
S81-PMC3257641	PMC3257641	3/2010	S81-PMC3257641	['there was a positive CORRELATION between the maternal 25(Oh)D level and the Fetal Metaphyseal cross-sectional area, with the latter 5% and 14% greater in fetuses of mothers who were Vitamin D insufficient (Serum 25(Oh)D 25-50 nmol/l) and Vitamin D deficient (Serum 25(Oh)D < 25 nmol/l) compared to Vitamin D sufficient mothers (Serum 25(Oh)D > 50 nmol/l) [56].']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('UBERON_0000922', 'embryo', 76, 'fetal'), ('UBERON_0001438', 'metaphysis', 82, 'metaphyseal'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001977', 'blood serum', 206, 'serum'), ('CHEBI_71657', 'versiconol acetate', 212, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 218, 'D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0001977', 'blood serum', 259, 'serum'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 265, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D'), ('UBERON_0001977', 'blood serum', 328, 'serum'), ('CHEBI_71657', 'versiconol acetate', 334, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 334, '25(OH)D')]
S10-PMC3296991	PMC3296991	2/2012	S10-PMC3296991	['HOWEVER, the behavior of these BIOMARKERS in the fetus and their RELATIONSHIP with Vitamin D status and neonatal bone mineralization are POORLY characterized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBLEM_COMPLICATION', 137)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
S12-PMC3347007	PMC3347007	4/2012	S12-PMC3347007	['during Pregnancy, Vitamin D is transported from mother to fetus through the Placenta in the form of 25(Oh)D which is also the established MARKER of Vitamin D status [1,3,4].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0001987', 'placenta', 76, 'placenta'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S0-PMC3347028	PMC3347028	3/2012	S0-PMC3347028	['Vitamin D and its ROLE during Pregnancy in attaining optimal health of mother and fetus\n\nabstract\nDESPITE its discovery a hundred years ago, Vitamin D has emerged as one of the most CONTROVERSIAL Nutrients and prohormones of the 21st century.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 30, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_33284', 'nutrient', 196, 'nutrients')]
S17-PMC3347028	PMC3347028	3/2012	S17-PMC3347028	['in the sections ahead, we will FOCUS on one Micronutrient—Vitamin D—and will discuss WHAT we KNOW and what we surely do NOT KNOW in the context of the Pregnant woman and her developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('EXPLICIT_QUESTION', 85), ('INCOMPLETE_EVIDENCE', 93), ('FULL_UNKNOWN', 120)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 44, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant')]
S18-PMC3347028	PMC3347028	3/2012	S18-PMC3347028	['during this foray into the world of Vitamin D and the fetus, we MUST first define WHAT Vitamin D is, WHAT it is not, and review the Metabolic pathways LINKED with Vitamin D.\n\n2.']	[('IMPORTANT_CONSIDERATION', 64), ('EXPLICIT_QUESTION', 82), ('EXPLICIT_QUESTION', 101), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0008152', 'metabolic process', 132, 'metabolic'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S70-PMC3347028	PMC3347028	3/2012	S70-PMC3347028	['[23], SHOWED that Ifn-Γ-mediated Antimicrobial activity of Human Macrophages, especially IMPORTANT in hiv and tuberculosis patients, is DEPENDENT on Vitamin D. BOTH STUDY findings have IMPLICATIONS for the Pregnant woman and her developing fetus, BUT our understanding of such processes following maternal exposure to a pathogen or maternal infection REMAINS SCANT.']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 185), ('ANOMALY_CURIOUS_FINDING', 247), ('INCOMPLETE_EVIDENCE', 351), ('INCOMPLETE_EVIDENCE', 359)]	8	[('PR_000008920', 'interferon alpha-7', 18, 'IFN-γ'), ('CHEBI_65381', 'albizoside C', 33, 'antimicrobial'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('CL_0000235', 'macrophage', 65, 'macrophages'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnant')]
S143-PMC3347028	PMC3347028	3/2012	S143-PMC3347028	['from the prior sections, IT IS CLEAR that Vitamin D deficiency during Pregnancy is common throughout the world YET WHAT EFFECT does deficiency have on the mother and her developing fetus?']	[('PROBABLE_UNDERSTANDING', 25), ('ANOMALY_CURIOUS_FINDING', 111), ('EXPLICIT_QUESTION', 115), ('SUPERFICIAL_RELATIONSHIP', 120), ('EXPLICIT_QUESTION', 186)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
S145-PMC3347028	PMC3347028	3/2012	S145-PMC3347028	['with SEVERE maternal Vitamin D deficiency, the fetus rarely MAY develop rickets in utero with manifestation at Birth [96].']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 60)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007567', 'parturition', 111, 'birth')]
S240-PMC3347028	PMC3347028	3/2012	S240-PMC3347028	['WHILE there REMAINS much to be DISCOVERED and learned about Vitamin D’s EFFECT on the mother and her developing fetus, there is enough EVIDENCE TO SUPPORT the PREMISE that deficiency is not healthful for either the mother or fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S42-PMC3409554	PMC3409554	7/2012	S42-PMC3409554	['calf and pork Liver have a high content of Iron with a good bioavailability, but the danish health authorities ADVISE Pregnant women not to consume pork Liver and pork Liver paté due to the high content of Vitamin A, which POSSIBLY MAY cause malformations in the fetus [18].']	[('FUTURE_WORK', 111), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 232)]	3	[('UBERON_0002107', 'liver', 14, 'liver'), ('CHEBI_24870', 'ion', 43, 'iron'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('UBERON_0002107', 'liver', 153, 'liver'), ('UBERON_0002107', 'liver', 168, 'liver'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A')]
S15-PMC3470091	PMC3470091	9/2012	S15-PMC3470091	['these changes occur ACCORDING TO the needs for the mineralization of the fetus Bones as well as adequate secretion of Vitamin D in mother’s Milk.1\nDUE TO rapid fetal development, PARTICULARLY bone Calcification at the terminal stages of Pregnancy, there is a POSSIBILITY of Vitamin D deficiency to occur in mothers.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('PROBABLE_UNDERSTANDING', 147), ('IMPORTANT_CONSIDERATION', 179), ('INCOMPLETE_EVIDENCE', 259)]	4	[('UBERON_0001474', 'bone element', 79, 'bones'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001913', 'milk', 140, 'milk'), ('GO_0051301', 'cell division', 197, 'calcification'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
S16-PMC3470091	PMC3470091	9/2012	S16-PMC3470091	['SINCE, fetus and baby are both DEPENDENT upon mother for Blood and milk respectively, mother’s Vitamin D supplementation is highly VITAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 131)]	3	[('UBERON_0000178', 'blood', 57, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
S24-PMC3472720	PMC3472720	8/2012	S24-PMC3472720	['in this series of experiments, ONLY the Pregnant f0female Mice and their Growing Fetuses were Vitamin D deficient.']	[('ANOMALY_CURIOUS_FINDING', 31)]	1	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'mice'), ('GO_0040007', 'growth', 73, 'growing'), ('UBERON_0000309', 'body wall', 81, 'fetuses'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S258-PMC3586494	PMC3586494	2/2013	S258-PMC3586494	['in RELATING maternal Micronutrient Intake with fetal Glucocorticoid exposure, a Mouse MODEL of maternal dietary restriction of copper, zinc, and Vitamin E DEMONSTRATED reduced activity level of Placental 11 Β -Hydroxysteroid dehydrogenase-2, an enzyme that PROTECTS the fetus from overexposure to maternal Glucocorticoids [113].']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 257)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 21, 'micronutrient'), ('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_24261', 'glucocorticoid', 53, 'glucocorticoid'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'mouse'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin E'), ('UBERON_0001987', 'placenta', 194, 'placental'), ('CHEBI_36844', '7-hydroxy steroid', 207, 'β -hydroxysteroid'), ('CHEBI_36597', 'phthalazine', 306, 'glucocorticoids')]
S198-PMC3599191	PMC3599191	1/2013	S198-PMC3599191	['furthermore, levels of maternal Vitamin E AFFECT the development of fetal biometrics (Crown-Rump length, Femur length and biparietal diameter) and Lung Development: for every millimeter of increase in fetus length, there is an increase of up to 5 ml of fev1and 6 ml of fvc [107].']	[('SUPERFICIAL_RELATIONSHIP', 42)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin E'), ('UBERON_0002283', 'nail matrix', 86, 'crown-rump'), ('UBERON_0000981', 'femur', 105, 'femur'), ('GO_0030324', 'lung development', 147, 'lung development'), ('UBERON_0002048', 'lung', 147, 'lung')]
S17-PMC3651971	PMC3651971	5/2013	S17-PMC3651971	"[""DEFICIENCY of essential Nutrients CAN harm the fetus; NO RESEARCH to date has examined the long-term EFFECT of early Vitamin A deficiency on children's cognitive or motor skills.""]"	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_33284', 'nutrient', 24, 'nutrients'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A')]
S19-PMC3651971	PMC3651971	5/2013	S19-PMC3651971	['this research SUGGESTS that Central Nervous System Development MAY BE PROTECTED in Vitamin A deficiency, POSSIBLY BECAUSE Vitamin A is preferentially allocated to the developing fetus.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 105), ('PROBABLE_UNDERSTANDING', 114)]	5	[('GO_0003204', 'cardiac skeleton development', 28, 'central nervous system development'), ('UBERON_0001017', 'central nervous system', 28, 'central nervous system'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
S24-PMC3651971	PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
S44-PMC3659910	PMC3659910	1/2013	S44-PMC3659910	['the REQUIREMENT for Vitamin D in maintaining normal Calcium Metabolism throughout Pregnancy and Lactation in mothers, fetuses and newborn infants is STILL CONTROVERSIAL.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 52, 'calcium metabolism'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007595', 'lactation', 96, 'lactation')]
S52-PMC3659910	PMC3659910	1/2013	S52-PMC3659910	['ALTHOUGH transplacental Transport has NOT BEEN STUDIED in Humans, Vitamin D passage from the mother to the fetus WOULD BE facilitated by Serum concentrations of 1,25(Oh) 2D being higher in the maternal compared to the fetal Circulations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 38), ('FUTURE_PREDICTION', 113)]	3	[('GO_0006809', 'nitric oxide biosynthetic process', 24, 'transport'), ('NCBITaxon_9606', 'Homo sapiens', 58, 'humans'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 166, 'OH) 2D'), ('UBERON_0002595', 'orbital sulcus', 224, 'circulations')]
S128-PMC3659910	PMC3659910	1/2013	S128-PMC3659910	['a RECENT STUDY provides EVIDENCE with reference to the CONSEQUENCES of Vitamin D deficiency on the Neurodevelopment Of the Fetus during Pregnancy in a Rat MODEL.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0001503', 'ossification', 99, 'neurodevelopment of ... fetus'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 151, 'rat')]
S22-PMC3685533	PMC3685533	6/2013	S22-PMC3685533	['in utero, the fetus is wholly dependent on the mother for Vitamin D. the 25Ohd crosses the Placenta into the Blood stream of the fetus with a half-Life of APPROXIMATELY 2 months [7].']	[('INCOMPLETE_EVIDENCE', 155)]	1	"[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 73, '25OHD'), ('UBERON_0001987', 'placenta', 91, 'placenta'), ('UBERON_0000178', 'blood', 109, 'blood'), ('UBERON_0000104', 'life cycle', 147, 'life')]"
S13-PMC3702245	PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	"[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]"
S15-PMC3702245	PMC3702245	6/2013	S15-PMC3702245	['IN GENERAL, Cord Blood 25(Oh)D concentrations are APPROXIMATELY 60%–89% of the maternal value.11,17,35,41–47THEREFORE, maintaining optimum Vitamin D nutrition during Pregnancy is ESSENTIAL for PREVENTION of hypovitaminosis D in the fetus and Vitamin D deficiency at Birth and in early infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 223, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('GO_0007567', 'parturition', 266, 'birth')]
S19-PMC3702245	PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
S25-PMC3702245	PMC3702245	6/2013	S25-PMC3702245	['there is CONTROVERSY concerning the EFFECT of maternal Vitamin D deficiency on Skeletal Development Of the Fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0000901', 'translation repressor activity, non-nucleic acid binding', 79, 'skeletal development of ... fetus'), ('UBERON_0004288', 'skeleton', 79, 'skeletal')]
S27-PMC3702245	PMC3702245	6/2013	S27-PMC3702245	['high resolution three-dimensional ultrasound assessment in a study from the uk FOUND greater splaying of the distal Femoral Metaphysis in the fetus when maternal Serum 25(Oh)D was <50 nmol/l,60AND the authors SUGGESTED that this FINDING is SIMILAR TO radiologic features in Vitamin D-deficient rickets.']	[('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 209), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 240)]	5	[('UBERON_0013751', 'metaphysis of radius', 116, 'femoral metaphysis'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_63056', 'zinc cation', 168, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 174, 'D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
S32-PMC3702245	PMC3702245	6/2013	S32-PMC3702245	['SEVERE hypocalcemia occasionally presenting as neonatal seizures is a known COMPLICATION of maternal Vitamin D deficiency during Pregnancy.66,67\n\nextraskeletal and noncalcemic COMPLICATIONS of Vitamin D deficiency during Pregnancy\nseveral Extraskeletal COMPLICATIONS of Vitamin D deficiency during Pregnancy HAVE BEEN REPORTED in the mother, fetus, and infant.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBLEM_COMPLICATION', 76), ('PROBLEM_COMPLICATION', 176), ('PROBLEM_COMPLICATION', 253), ('INCOMPLETE_EVIDENCE', 308)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 239, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnancy')]
S89-PMC3827489	PMC3827489	10/2013	S89-PMC3827489	['EFFECTS of maternal Vitamin D insufficiency/deficiency on infants and children\nstudies have SUGGESTED that Vitamin D concentrations in the fetus and newborn are highly DEPENDENT on and significantly RELATED to maternal Serum 25(Oh)D concentrations61-64).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_71657', 'versiconol acetate', 225, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 225, '25(OH ... D')]
S17-PMC3873449	PMC3873449	12/2013	S17-PMC3873449	['adequate 25(Oh)D levels are particularly IMPORTANT for women who Become Pregnant, BECAUSE mothers HAVE to sustain their own Vitamin D stores as well as those of their fetuses [2,3].']	[('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 82), ('IMPORTANT_CONSIDERATION', 98)]	3	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('GO_0007567', 'parturition', 65, 'become'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S2-PMC3888066	PMC3888066	12/2012	S2-PMC3888066	['HOWEVER, Vitamin A deficiency HAS long BEEN KNOWN to be deleterious to the mother and fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
S12-PMC3888066	PMC3888066	12/2012	S12-PMC3888066	['this NOTION is BASED ON the KNOWN Teratogenic EFFECTS of Retinoic Acids on the Central Nervous System,1–3the CALCULATED dose of Retinol and Beta Carotene Ingested by the mother during early Pregnancy, and STRONG EVIDENCE that the fetus Metabolizes Beta Carotene to Retinoids and has LIMITED ability to store Beta Carotene in Fat Cells.4–7\nin 1995, rothman et al DEMONSTRATED that high maternal dietary intake of Vitamin A in the form of Retinol, ie, >10,000 iu/day, particularly in the first Trimester, MAY BE ASSOCIATED with Cranial-Neural-Crest Birth defects.8using a smooth regression curve, THIS study of 22,748 Pregnant women and their offspring IDENTIFIED 1 infant in 57 with malformations that COULD BE ATTRIBUTED to the intake of supplements of Preformed Vitamin A at a dose >10,000 iu/day.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('ANOMALY_CURIOUS_FINDING', 21), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 283), ('INCOMPLETE_EVIDENCE', 362), ('INCOMPLETE_EVIDENCE', 503), ('SUPERFICIAL_RELATIONSHIP', 510), ('QUESTION_ANSWERED_BY_THIS_WORK', 595), ('INCOMPLETE_EVIDENCE', 651), ('INCOMPLETE_EVIDENCE', 701), ('SUPERFICIAL_RELATIONSHIP', 710)]	16	[('CHEBI_50905', 'teratogenic agent', 34, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 57, 'retinoic acids'), ('UBERON_0001017', 'central nervous system', 79, 'central nervous system'), ('CHEBI_26536', 'retinoic acid', 128, 'retinol'), ('CHEBI_51438', 'D-isoascorbic acid', 140, 'beta carotene'), ('GO_0007631', 'feeding behavior', 154, 'ingested'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0008152', 'metabolic process', 236, 'metabolizes'), ('CHEBI_51438', 'D-isoascorbic acid', 248, 'beta carotene'), ('CHEBI_26537', 'retinoid', 265, 'retinoids'), ('CHEBI_51438', 'D-isoascorbic acid', 308, 'beta carotene'), ('CL_0000136', 'fat cell', 325, 'fat cells'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 437, 'retinol'), ('GO_0009294', 'DNA mediated transformation', 492, 'trimester'), ('UBERON_0001456', 'face', 526, 'cranial'), ('UBERON_0002342', 'neural crest', 534, 'neural-crest'), ('GO_0007567', 'parturition', 547, 'birth'), ('GO_0007565', 'female pregnancy', 616, 'pregnant'), ('GO_0007565', 'female pregnancy', 753, 'preformed'), ('CHEBI_27300', 'vitamin D', 763, 'vitamin A')]
S19-PMC3888066	PMC3888066	12/2012	S19-PMC3888066	['finally, neonatal levels of 13-Cis Retinoic Acid are proportionately higher than All-Trans Retinoic Acid levels when compared to maternal levels, SUGGESTING that, in newborns, the equilibrium of cis and trans isomers is shifted toward the more Teratogenic 13-cis Isomer.12this is an IMPORTANT FINDING and POINTS to a deficit in studies that DO NOT demonstrate an association between excess Vitamin A and Birth defects, AS most DO NOT measure levels of Retinoic Acid Isomers in the fetus or newborn.']	[('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 283), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 341), ('PROBABLE_UNDERSTANDING', 419), ('INCOMPLETE_EVIDENCE', 427)]	7	[('CHEBI_61206', '2-hexenoic acid', 28, '13-cis retinoic acid'), ('CHEBI_16553', 'UDP-4-dehydro-6-deoxy-D-glucose', 81, 'all-trans retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 244, 'teratogenic'), ('GO_0031649', 'heat generation', 244, 'teratogenic'), ('SO_0001017', 'silent_mutation', 263, 'isomer'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin A'), ('GO_0007567', 'parturition', 404, 'birth'), ('CHEBI_26536', 'retinoic acid', 452, 'retinoic acid'), ('SO_0001060', 'sequence_variant', 466, 'isomers')]
S45-PMC3888066	PMC3888066	12/2012	S45-PMC3888066	['examples of non-fortified Foods that are high in Vitamin A or beta Carotene are listed intable 5.37\n\ncalculation of Vitamin A and beta Carotene intake during Pregnancy\nthe absorption, Metabolism, storage, and Excretion Of Beta Carotene and Retinol in the mother are NOT COMPLETELY UNDERSTOOD; HOWEVER, most investigators agree that consumption of these forms of Vitamin A is RELATED to maternal Serum levels.38–40in ONE STUDY, maternal diet INFLUENCED Cord levels of Beta Carotene, but not Vitamin A.41absorption Of Beta Carotene from raw carrots and a low fat diet is very low compared to carrot juice.42according to current literature, 6 μg of Ingested Beta Carotene convert to 1 Retinol equivalent, or 1 μg Retinol, but ratios have ranged from 3.3:1 to 26:1.43,44\nbased on the discussion above, it MAY BE apparent that Maternal Ingestion of non-Beta Carotene sources of Vitamin A in foods + fortified foods + nutritional supplements would not LIKELY elevate Retinoic Acid levels in the fetus to Teratogenic levels.']	[('INCOMPLETE_EVIDENCE', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('SUPERFICIAL_RELATIONSHIP', 375), ('INCOMPLETE_EVIDENCE', 416), ('SUPERFICIAL_RELATIONSHIP', 441), ('INCOMPLETE_EVIDENCE', 801), ('PROBABLE_UNDERSTANDING', 946)]	7	[('CHEBI_33290', 'food', 26, 'foods'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_23042', 'carotene', 67, 'carotene'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin A'), ('CHEBI_23042', 'carotene', 135, 'carotene'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('GO_0008152', 'metabolic process', 184, 'metabolism'), ('GO_0007530', 'sex determination', 209, 'excretion of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 222, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 240, 'retinol'), ('GO_0060033', 'anatomical structure regression', 240, 'retinol'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin A'), ('UBERON_0001977', 'blood serum', 395, 'serum'), ('UBERON_0002240', 'spinal cord', 452, 'cord'), ('CHEBI_51438', 'D-isoascorbic acid', 467, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin A'), ('GO_0046311', 'prenylcysteine biosynthetic process', 513, 'of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 516, 'beta carotene'), ('GO_0007631', 'feeding behavior', 646, 'ingested'), ('CHEBI_51438', 'D-isoascorbic acid', 655, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 682, 'retinol'), ('CHEBI_26536', 'retinoic acid', 710, 'retinol'), ('GO_0007618', 'mating', 822, 'maternal'), ('GO_0007631', 'feeding behavior', 831, 'ingestion'), ('CHEBI_51438', 'D-isoascorbic acid', 848, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 961, 'retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 998, 'teratogenic'), ('GO_0031649', 'heat generation', 998, 'teratogenic')]
S97-PMC3901983	PMC3901983	1/2013	S97-PMC3901983	['it HAS BEEN SUGGESTED that the Vitamin A status of Pregnant women CAN INFLUENCE Vitamin A stores in the fetus Liver [20].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A'), ('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('UBERON_0002107', 'liver', 110, 'liver')]
S35-PMC3973641	PMC3973641	4/2014	S35-PMC3973641	['DESPITE these STUDIES, LITTLE IS KNOWN about the EFFECTS of Vitamin B deficiency in fetuses and neonates on their Methionine-Homocysteine Metabolism programming and subsequent consequences to the Brain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('FULL_UNKNOWN', 23), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('GO_0006555', 'methionine metabolic process', 114, 'methionine- ... metabolism'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 125, 'homocysteine'), ('UBERON_0000955', 'brain', 196, 'brain')]
S19-PMC3991049	PMC3991049	11/2013	S19-PMC3991049	['Vitamin D receptors can be found in most Tissues and cells in the body, and the IMPACT of a Vitamin D deficiency on the developing fetus and maternal health is of significant CONCERN.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 175)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 41, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
S20-PMC3991049	PMC3991049	11/2013	S20-PMC3991049	['BECAUSE 25-Hydroxyvitamin D crosses the Placenta,1and Fetal and Cord Blood levels of the new born Vitamin D status CORRELATE with the mother levels of Vitamin D,2,3a higher level of Vitamin D in the fetus MAY raise the concern of POSSIBLE POTENTIAL fetal harm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 230), ('INCOMPLETE_EVIDENCE', 239)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 8, '25-hydroxyvitamin D'), ('UBERON_0001987', 'placenta', 40, 'placenta'), ('UBERON_0000922', 'embryo', 54, 'fetal'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
S192-PMC4045304	PMC4045304	2/2014	S192-PMC4045304	['BECAUSE activated Vitamin D (1, 25-Dihydroxy Vitamin D), a Secosteroid, upregulates the Dna Repair Gene, Vitamin deficiency during development MAY inhibit the Repair of de novo dna mutations in fetuses and infants and THUS CONTRIBUTE to risk of autism.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 223)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_35785', 'sphingoid', 59, 'secosteroid'), ('GO_0006281', 'DNA repair', 88, 'DNA repair'), ('SO_0000704', 'gene', 99, 'gene'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('GO_0006281', 'DNA repair', 159, 'repair')]
S3249-PMC4113768	PMC4113768	7/2014	S3249-PMC4113768	['to date, there is NO STUDY investigating the EFFECT of maternal Vitamin D deficiency on the Human fetus.']	[('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 92, 'human')]
S89-PMC4346113	PMC4346113	3/2015	S89-PMC4346113	['low maternal Protein Consumption or poor Vitamin B and methionine status are ASSOCIATED with behavioral and Cardiovascular abnormalities, and sex-specific changes in Hepatic Gene Expression in Rat fetuses and changes in Imprinted Gene Expression in the Rat Embryo-fetal axis [40,74-76].']	[('SUPERFICIAL_RELATIONSHIP', 77)]	1	[('GO_0006412', 'translation', 13, 'protein consumption'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('UBERON_0004535', 'cardiovascular system', 108, 'cardiovascular'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('GO_0010467', 'gene expression', 174, 'gene expression'), ('SO_0000704', 'gene', 174, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 193, 'rat'), ('GO_0071514', 'genetic imprinting', 220, 'imprinted'), ('GO_0010467', 'gene expression', 230, 'gene expression'), ('SO_0000704', 'gene', 230, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 253, 'rat'), ('UBERON_0000922', 'embryo', 257, 'embryo')]
S154-PMC4405493	PMC4405493	4/2015	S154-PMC4405493	['during Pregnancy, 25-Oh Vitamin D diffuses across the Placenta and the fetus relies entirely on the Vitamin D stores of the mother: IF the mother is deficient, so is the fetus [5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 132)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 18, '25-OH'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 54, 'placenta'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
S95-PMC4466139	PMC4466139	6/2015	S95-PMC4466139	['AS ALREADY KNOWN, Placental Transfer provides Vitamin D from mother to fetus, especially in the last trimester of Gestation [31] THUS neonatal and maternal 25Ohd levels are closely LINKED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 181)]	4	"[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0006412', 'translation', 28, 'transfer'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 156, '25OHD')]"
S37-PMC4499946	PMC4499946	7/2015	S37-PMC4499946	['HOWEVER, SOME Animal [27] and observational [21,28] studies have SUGGESTED an EFFECT of maternal Prenatal Vitamin D status on growth of the fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('GO_0007565', 'female pregnancy', 97, 'prenatal'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
S15-PMC4595656	PMC4595656	10/2015	S15-PMC4595656	['the increased demands of the developing fetus combined with a POSSIBLE decrease in environmental exposure to sunlight, MAY result in diminished circulating Vitamin D (hillman and haddad,1976; markestad et al.,1983).']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 119)]	2	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
S10-PMC4598849	PMC4598849	10/2015	S10-PMC4598849	['maternal Vitamin D deficiency during Pregnancy is a SIGNIFICANT PUBLIC HEALTH PROBLEM GLOBALLY78DUE to the combined EFFECTS of limited sunlight exposure, INADEQUATE intake, and additional growth NEEDS of the fetus.']	[('IMPORTANT_CONSIDERATION', 52), ('PROBLEM_COMPLICATION', 78), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 116), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy')]
S2-PMC4605923	PMC4605923	11/2015	S2-PMC4605923	['Food intake is a WELL-known environmental FACTOR that INFLUENCES Allergy Development and three specific Nutrients-Vitamin D, Omega 3 polyunsaturated Fatty Acids and Folate-have RECENTLY attracted ATTENTION.1\nthe methyl donor Folate is a WELL-KNOWN Nutrient supplement given during early Pregnancy to prevent neutral Tube defects in the developing fetus.']	[('PROBABLE_UNDERSTANDING', 17), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 237)]	6	"[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0060021', 'roof of mouth development', 65, 'allergy development'), ('CHEBI_33284', 'nutrient', 104, 'nutrients'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_82673', ""2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine"", 125, 'omega 3'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 165, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 225, 'folate'), ('CHEBI_33284', 'nutrient', 248, 'nutrient'), ('GO_0007565', 'female pregnancy', 287, 'pregnancy'), ('UBERON_0000025', 'tube', 316, 'tube')]"
S85-PMC4613350	PMC4613350	9/2015	S85-PMC4613350	['matched for body mass index (bmi);6exclusion: Vitamin C and/or Vitamin E supplements, history of major medical complications, major fetal defects, repeated spontaneous abortion, use of an Illicit Drug or Warfarin treatment during the current Pregnancy;7inclusion: nulliparous women with singleton Pregnancies without major fetal chromosomal or structural anomaly;8exclusion: women who had a previous fetus with a chromosomal abnormality and women with Insulin-dependent diabetes mellitus;9exclusion: aids or hepatitis, cases of major fetal anomaly, fetal death and women with Placenta previa, Placenta accrete, or Placental abruption;10general population, singleton Pregnancies;11a priori high risk Pregnancies;12general population;13inclusion: singleton Pregnancy, exclusion: diabetes and chromosomal abnormalities;14exclusion: chronic Hepatic or Renal diseases, Pregnancies with major fetal abnormalities and those ending in termination, Miscarriage or fetal death <24 weeks;15exclusion : known aneuploidy and major congenital malformations;16exclusion: Miscarriages;17exclusion: congenital abnormalities or Medication use;18randomly selected controls;19exclusion: multifetal Gestation, diabetes, chromosomal or structural abnormalities;20exclusion: increased risk factors of pe, sga or ptb, known major fetal anomaly or abnormal karyotype, intervention that MAY modify Pregnancy outcome such as treatment with Aspirin or Progesterone;21inclusion: history of pe in a previous Pregnancy, chronic hypertension, chronic Renal disease, Antiphospholipid syndrome, systemic lupus erythematosus, Pregestational diabetes mellitus, obesity (bmi ≥ 30 kg/m2).']	[('INCOMPLETE_EVIDENCE', 1361)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin E'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 188, 'illicit drug'), ('CHEBI_10033', 'warfarin', 204, 'warfarin'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 297, 'pregnancies'), ('PR_000045358', 'insulin family protein', 452, 'insulin'), ('UBERON_0001987', 'placenta', 576, 'placenta'), ('UBERON_0001987', 'placenta', 593, 'placenta'), ('UBERON_0001987', 'placenta', 614, 'placental'), ('GO_0007565', 'female pregnancy', 666, 'pregnancies'), ('GO_0007565', 'female pregnancy', 699, 'pregnancies'), ('GO_0007565', 'female pregnancy', 755, 'pregnancy'), ('UBERON_0002107', 'liver', 837, 'hepatic'), ('UBERON_0002113', 'kidney', 848, 'renal'), ('GO_0007565', 'female pregnancy', 864, 'pregnancies'), ('GO_0046660', 'female sex differentiation', 940, 'miscarriage'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 1056, 'miscarriages'), ('CHEBI_60211', 'compound Z', 1110, 'medication'), ('GO_0007565', 'female pregnancy', 1178, 'gestation'), ('GO_0007565', 'female pregnancy', 1372, 'pregnancy'), ('CHEBI_2904', 'atenolol', 1413, 'aspirin'), ('CHEBI_17026', 'progesterone', 1424, 'progesterone'), ('GO_0007565', 'female pregnancy', 1478, 'pregnancy'), ('UBERON_0002113', 'kidney', 1519, 'renal'), ('CHEBI_16240', 'hydrogen peroxide', 1534, 'antiphospholipid'), ('GO_0007565', 'female pregnancy', 1591, 'pregestational')]
S0-PMC4729160	PMC4729160	1/2016	S0-PMC4729160	['prevalence and INFLUENCE FACTORS of Vitamin A deficiency of chinese Pregnant women\n\nabstract\n\nbackground\nvitamin a plays an IMPORTANT ROLE in the periods of rapid Cellular Growth and Differentiation, especially during Pregnancy, which is supplied by the mother to the fetus.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 25), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0001775', 'cell activation', 163, 'cellular growth ... differentiation'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy')]
S24-PMC4785305	PMC4785305	3/2016	S24-PMC4785305	"[""ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially.""]"	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
S109-PMC4811107	PMC4811107	3/2016	S109-PMC4811107	"[""NOT ONLY do these studies INDICATE that use of the Prenatal level of 25(Oh)D to represent the child's early Life Vitamin D level is not specific, but also the data SUGGEST that a maternal THRESHOLD exists below which the mother LIMITS her CONTRIBUTION of 25(Oh)D to the fetus.""]"	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 188), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 257, '(OH)D')]
S128-PMC4829940	PMC4829940	5/2016	S128-PMC4829940	['given that Vitamin D status fluctuates throughout Pregnancy, IT IS POSSIBLE that the fetus is more sensitive to Vitamin D levels at certain Gestational periods[6].']	[('INCOMPLETE_EVIDENCE', 61)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'gestational')]
S55-PMC4918713	PMC4918713	6/2015	S55-PMC4918713	['Animal STUDIES HAVE SHOWN that neonatal copper deficiency is ASSOCIATED with developmental abnormalities and altered Thyroid and Immune function.38\na similar DIFFERENTIAL EFFECT between mother and fetus is also SEEN in Vitamin A Metabolism.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 211)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 219, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 227, 'A')]
S265-PMC4934634	PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
S0-PMC4944244	PMC4944244	7/2016	S0-PMC4944244	['risk factors for Antenatal hypovitaminosis d in an urban district in malaysia\n\nabstract\n\nbackground\nPregnant women form one of the HIGH RISK groups facing hypovitaminosis d. low level of Vitamin D will AFFECT directly OR indirectly both mother and fetus.']	[('IMPORTANT_CONSIDERATION', 131), ('SUPERFICIAL_RELATIONSHIP', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	3	[('GO_0007567', 'parturition', 17, 'antenatal'), ('GO_0007565', 'female pregnancy', 100, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
S227-PMC4944244	PMC4944244	7/2016	S227-PMC4944244	['Calcium supplement with Vitamin D SHOULD BE given earlier to those who do not Consume adequate milk during Pregnancy to prevent adverse health EFFECTS to the mother and fetus.']	[('FUTURE_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 143)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 78, 'consume'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy')]
S132-PMC4949006	PMC4949006	7/2016	S132-PMC4949006	['supplementation does prevent and cure this condition.93–95all studies to date fail to show any significant EFFECTS of Vitamin A supplementation on Pregnancy outcomes for mother or fetus.96more than 10,000 iu of Vitamin A supplementation per day (4 times the recommended daily allowance) increases the risk of cleft lip or palate, Hydrocephalus, and Heart defects.']	[('SUPERFICIAL_RELATIONSHIP', 107)]	1	[('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('UBERON_4100114', 'anterior distal condyle of femur', 330, 'hydrocephalus'), ('UBERON_0000948', 'heart', 349, 'heart')]
S138-PMC4949006	PMC4949006	7/2016	S138-PMC4949006	['Vitamin D\nadequate Vitamin D status during Pregnancy is NECESSARY to ensure appropriate maternal responses to the calcium demands of the fetus for bone Mineral accretion.']	[('IMPORTANT_CONSIDERATION', 56)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_46662', 'mineral', 152, 'mineral')]
S148-PMC4949006	PMC4949006	7/2016	S148-PMC4949006	['SOME STUDIES REPORT higher long-bone density in fetuses of women with adequate amounts of Vitamin D,115,116but the numbers are SMALL.117the general RECOMMENDATION is 1000 to 2000 mg/d of supplementation, BUT there are no AGREED-UPON levels for sufficiency or insufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('INCOMPLETE_EVIDENCE', 221)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy')]
S19-PMC4997421	PMC4997421	8/2016	S19-PMC4997421	['SINCE there is no de novo fetal Synthesis Of Vitamin A, the fetus relies completely on circulating maternal Vitamin A.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0)]	2	[('GO_0006557', 'S-adenosylmethioninamine biosynthetic process', 32, 'synthesis of vitamin A'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 53, 'A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 116, 'A')]
S20-PMC4997421	PMC4997421	8/2016	S20-PMC4997421	['signs of Vitamin A deficiency MAY not be observed in the mother, but the rapidly developing fetus is more vulnerable to these EFFECTS [13].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
S21-PMC4997421	PMC4997421	8/2016	S21-PMC4997421	['since maternal stores will be rapidly depleted in order to provide Vitamin A to the developing fetus [14], it is CRITICAL that women of Childbearing age are sufficient in Vitamin A prior to Conception.']	[('IMPORTANT_CONSIDERATION', 113)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 136, 'childbearing'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin A'), ('GO_0007620', 'copulation', 190, 'conception')]
S32-PMC4997421	PMC4997421	8/2016	S32-PMC4997421	['we chose these categories based on evidence that maternal stores will be rapidly depleted by the developing fetus [14], therefore we deemed it IMPORTANT that a woman begins a Pregnancy with sufficient Vitamin A stores.']	[('IMPORTANT_CONSIDERATION', 143)]	1	[('GO_0007565', 'female pregnancy', 175, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin A')]
S39-PMC4997421	PMC4997421	8/2016	S39-PMC4997421	['Carotenes and beta-crytoxanthin have pre-Vitamin A activity, and lutein + zeaxanthin and Lycopene HAVE BEEN SHOWN in the literature to POTENTIALLY be important to the developing fetus [18,19].']	[('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 135)]	2	[('CHEBI_23042', 'carotene', 0, 'Carotenes'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_15948', 'lycopene', 89, 'lycopene')]
S71-PMC5024513	PMC5024513	9/2016	S71-PMC5024513	['caption (table-wrap): table 2\n\ncharacteristics of included studiesstudy informationparticipantssupplementsmeasurementqualitystudycountrystudy designstudy groupsnumberageinclusion criteriaexclusion criteriasupplement type and dosenumber with available dataestimated compliance: n (%)data collection method (s)time period(s)quality ratingbaker et.al (2009) [23]ukcross-sectional studyna50014–18singleton Pregnancy, age 14–18, Gestational age\u2009<\u2009=20\xa0weeksinability to provide informed consent, preeclampsia, Clotting disorders, hiv/aids, haemoglobinopathies, diabetes, Renal disease, hypertension, multiple Gestations, history of 3=\u2009>\u2009previous Miscarriagespreconception folic acid49834 (6.9)24\xa0h recall (multiple)third Trimester+Folic Acid in early pregnancy498220 (44.2)Iron in early pregnancy49839 (7.8)multivitamins in early pregnancy49819 (3.8)Folic Acid only in 3rd trimester2905 (1.7)Iron and Folic Acid in 3rd trimester29013 (4.5)Iron only in 3rd trimester29042 (14.5)multivitamins in 3rd trimester2907 (2.4)castillo-duran et.al (2001) [43]chilerctzinc supplemented24916.4 (mean)beginning Prenatal visits before 20\xa0weeks Gestation, aged <19 at estimated due dateadolescents whose background included chronic diseases, Drug abuse, mental retardation, illiteracy or Pregnancy due to incest or rape20\xa0mg Zinc Sulphate dailyintervention group - 249at least 50\xa0% compliance24\xa0h Recall (multiple)second and third Trimester+placebo25840\xa0mg Iron Sulphateall participants - 507chan et.al (2006) [24]usarctcontrol group, 2 intervention groups excluded from review*2315–17enrolled before 20\xa0weeks Gestationhypertension, diabetes, Renal or Liver disease, alcohol or tobacco use, using medicines effecting Ca Metabolismno additional supplements reportedfood diary (weighing not mentioned)second and third Trimester−/+chang et.al (2003) [37]usaretrospective chart reviewna91812–17self-reported racial group as african-american; singleton Pregnancybirth results not AVAILABLE DUE TO abortion, Miscarriage or transfer of care90\xa0mg Carbonyl Iron daily plus additional up to 120\xa0mg for those classified as anaemic918not reportednot reportedsecond and third Trimester+dawson et.al (2000) [35]usarctone-a-day without iron2016–20aged 16–20, less than 16\xa0weeks Gestation, no Iron supplementation for previous 30\xa0dayshypertension; diabetes; other medical problems; haemoglobin <11\xa0g/dl; haematocrit <30\xa0%vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, Pantothenic Acid 10\xa0mg20not reportedvenous Blood samplesecond and third Trimester and Delivery−/+one-a-day with iron2018\xa0mg iron, vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, Niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, pantothenic Acid 10\xa0mg20derbyshire (2009) [39]ukcross-sectional studyna2015–19attending Antenatal classes or community clinicsincomplete diarynone reportedfood diary unweighedthird Trimester+gadowsky et.al (1995) [42]canadacross-sectional studyna5814–19not reportednot reportedfolic Acid mean 479\xa0μg/day5882\xa0%Venous Blood samplethird trimester+Elemental Iron mean 31.5\xa0mg/daycyanocobalamin (B12) mean 2.24\xa0μg/dgiddens et.al (2000) [27]usarct (subset from a larger study)na5913–18singleton Pregnancies, between 13 and 19\xa0weeks Gestationnot REPORTEDREPORTED that any contribution from Supplements was not included in analysisfood diary weighedmean over Pregnancy−/+ginde et.al (2010) [32]usasecondary analysis of cross sectional surveyna8413–19not reportednot reportedsome participants taking Vitamin D Supplementsnot reportednot reportedvenous Blood samplemean over Pregnancy+gutierrez et.al (1999) [28]usacross-sectional studyna4613–18self-identified ethnicity as mexican american, primigravida, 13–18 years of agehistory of Miscarriage or health problems, involved in competitive athletic performances or heavy exercise, planned to move away during study periodnone reported24\xa0h recall (single)second and third Trimester+iannotti et.al (2005) [36]usacross-sectional studyna8013–18self-reported racial group as african-american; singleton Pregnancynot reportednone reported10\xa0ml Venous Blood samplesecond and third trimesters+job et.al (1995) [41]australiacross-sectional studyna3513–19not reportednot reportednone REPORTED24\xa0h recallmean over Pregnancy+lee et.al (2013) [25]usacross-sectional studyna15613–18age 18 or under, carrying a single fetus, 12–30 weeks Gestation at recruitmentnot REPORTEDREPORTED that any CONTRIBUTION from Supplements was not included in analysis24\xa0h recall (multiple)<23\xa0weeks Gestation, 23–30 weeks Gestation and mean over Pregnancy+mcguire et.al.']	[('INCOMPLETE_EVIDENCE', 1954), ('PROBLEM_COMPLICATION', 1964), ('INCOMPLETE_EVIDENCE', 3401), ('INCOMPLETE_EVIDENCE', 4377), ('INCOMPLETE_EVIDENCE', 4553), ('SUPERFICIAL_RELATIONSHIP', 4579)]	6	[('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007565', 'female pregnancy', 424, 'gestational'), ('GO_0050817', 'coagulation', 504, 'clotting'), ('UBERON_0002113', 'kidney', 565, 'renal'), ('GO_0007565', 'female pregnancy', 603, 'gestations'), ('GO_0050788', 'sequestering of mercury', 640, 'miscarriagesPreconception'), ('GO_0009294', 'DNA mediated transformation', 715, 'trimester'), ('CHEBI_30751', 'formic acid', 725, 'Folic acid'), ('CHEBI_24870', 'ion', 767, 'Iron'), ('CHEBI_30751', 'formic acid', 844, 'Folic acid'), ('CHEBI_24870', 'ion', 886, 'Iron'), ('CHEBI_30751', 'formic acid', 895, 'folic acid'), ('CHEBI_24870', 'ion', 933, 'Iron'), ('GO_0007565', 'female pregnancy', 1092, 'prenatal'), ('GO_0007565', 'female pregnancy', 1124, 'gestation'), ('CHEBI_23888', 'drug', 1221, 'drug'), ('GO_0007565', 'female pregnancy', 1267, 'pregnancy'), ('CHEBI_10127', 'zonisamide', 1304, 'Zinc sulphate'), ('GO_0060033', 'anatomical structure regression', 1376, 'recall'), ('GO_0009294', 'DNA mediated transformation', 1410, 'trimester'), ('CHEBI_83530', 'atenolol-desisopropyl', 1436, 'iron sulphateAll'), ('GO_0051866', 'general adaptation syndrome', 1589, 'gestationHypertension'), ('UBERON_0002113', 'kidney', 1622, 'renal'), ('UBERON_0002107', 'liver', 1631, 'liver'), ('CHEBI_32588', 'potassium chloride', 1696, 'Ca'), ('GO_0008152', 'metabolic process', 1699, 'metabolismNo'), ('GO_0009294', 'DNA mediated transformation', 1795, 'trimester'), ('GO_0007605', 'sensory perception of sound', 1927, 'pregnancyBirth'), ('GO_0046660', 'female sex differentiation', 1981, 'miscarriage'), ('CHEBI_30255', 'sulfidocarbonate(.1-)', 2018, 'carbonyl iron'), ('GO_0009294', 'DNA mediated transformation', 2142, 'trimester'), ('GO_0007565', 'female pregnancy', 2242, 'gestation'), ('CHEBI_24870', 'ion', 2256, 'iron'), ('CHEBI_27300', 'vitamin D', 2403, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2421, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2438, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2455, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2474, 'thiamine'), ('CHEBI_16410', 'pyridoxamine', 2524, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2541, 'vitamin B'), ('CHEBI_7916', 'pantothenic acid', 2558, 'pantothenic acid'), ('UBERON_0000178', 'blood', 2601, 'blood'), ('GO_0009294', 'DNA mediated transformation', 2630, 'trimester'), ('GO_0007567', 'parturition', 2644, 'delivery'), ('CHEBI_27300', 'vitamin D', 2707, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2725, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2742, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2759, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2778, 'thiamine'), ('CHEBI_7542', 'neurotensin', 2814, 'niacin'), ('CHEBI_16410', 'pyridoxamine', 2828, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2845, 'vitamin B'), ('CHEBI_37527', 'acid', 2874, 'acid'), ('GO_0007567', 'parturition', 2950, 'antenatal'), ('GO_0009294', 'DNA mediated transformation', 3043, 'trimester'), ('CHEBI_37527', 'acid', 3145, 'Acid'), ('UBERON_0001638', 'vein', 3171, 'Venous'), ('UBERON_0000178', 'blood', 3178, 'blood'), ('CHEBI_4779', 'emedastine', 3206, 'Elemental'), ('CHEBI_24870', 'ion', 3216, 'Iron'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 3253, 'B12'), ('GO_0007565', 'female pregnancy', 3351, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3388, 'gestationNot'), ('CHEBI_33341', 'titanium atom', 3445, 'supplements'), ('GO_0007565', 'female pregnancy', 3513, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 3653, 'vitamin D'), ('CHEBI_46978', 'thiazinemonocarboxylic acid', 3663, 'supplementsNot'), ('UBERON_0000178', 'blood', 3705, 'blood'), ('GO_0007565', 'female pregnancy', 3727, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3887, 'miscarriage'), ('GO_0009294', 'DNA mediated transformation', 4074, 'trimester'), ('GO_0006915', 'apoptotic process', 4201, 'pregnancyNot'), ('UBERON_0001638', 'vein', 4241, 'Venous'), ('UBERON_0000178', 'blood', 4248, 'blood'), ('GO_0007565', 'female pregnancy', 4406, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4525, 'gestation'), ('CHEBI_33341', 'titanium atom', 4597, 'supplements'), ('GO_0007565', 'female pregnancy', 4669, 'gestation'), ('GO_0007565', 'female pregnancy', 4692, 'gestation'), ('GO_0007565', 'female pregnancy', 4716, 'pregnancy')]
S80-PMC5030591	PMC5030591	9/2016	S80-PMC5030591	"[""caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips.""]"	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
S74-PMC5045784	PMC5045784	10/2016	S74-PMC5045784	['fetal and newborn concentrations of 25(Oh)D DEPEND ON and CORRELATE with maternal Serum levels AS the fetus has no endogenous production of 25(Oh)d and DEPENDS on transplacental transfer.28THIS occurs MAINLY in the third trimester and THEREFORE, as we and others PREVIOUSLY REPORTED, preterm infants are at INCREASED RISK of Vitamin D deficiency.10,29our PRIOR STUDY DEMONSTRATED that Birth before 32 completed weeks of Gestation is an INDEPENDENT RISK FACTOR for low 25(Oh)d levels at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 235), ('INCOMPLETE_EVIDENCE', 263), ('IMPORTANT_CONSIDERATION', 307), ('INCOMPLETE_EVIDENCE', 355), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 436), ('SUPERFICIAL_RELATIONSHIP', 448)]	13	[('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_63056', 'zinc cation', 140, '25(OH'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('GO_0007567', 'parturition', 385, 'birth'), ('GO_0007565', 'female pregnancy', 420, 'gestation'), ('CHEBI_30778', 'gallic acid', 468, '25(OH)'), ('GO_0007567', 'parturition', 486, 'birth')]
S70-PMC5054480	PMC5054480	9/2016	S70-PMC5054480	['caption (table-wrap): table 2\n\nchanges in Calcium Homeostasis during Pregnancy and Lactationmeasured levelspregnant womanplacentafetuslactating womanserum Catotal Ca ↓Ionized Ca↔Intestinal Absorption twofold ↑active transfer DEPENDENT on Pthrp+ passive transferhigher than maternal levels; Regulated by fetal pthrpionized Ca slightly ↑Bone Resorption ↑Urinary Ca↑unknown↔pth↓↔no transferlowlowpthrpprogressively ↑ secretion by Decidua and Breastsno transfer; Placental and amniotic secretionhigher than in mothersecretion by the Umbilical Cord and Fetal Parathyroid Glands as early as 10 weeks↑↑: secretion by breasts25‐Vitamin D↔transfer; Placental hydroxylationrenal hydroxylation↔1,25‐dihydroxyvitamin dprogressive ↑ by 100%; Calbindin‐D9K ↑no transferlow↔1 α ‐hydroxylase activity↑stimulated by Estradiol, prolactin, Placental Lactogen, pthrppresentpresent in the Kidney↔Calcitonin↑ by 20%secretion by Thyroid and breastsno transfer; Placental secretion↑ in the first 6 weeks\nca, calcium level; Pthrp, Parathyroid Hormone‐Related Protein; Calbindin‐D9K, Vitamin D‐dependent calcium‐binding protein.']	[('SUPERFICIAL_RELATIONSHIP', 225)]	1	[('GO_0055073', 'cadmium ion homeostasis', 42, 'calcium homeostasis'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0001764', 'neuron migration', 83, 'lactationMeasured'), ('CHEBI_17793', 'calycosin', 155, 'CaTotal'), ('CHEBI_32588', 'potassium chloride', 163, 'Ca'), ('CHEBI_24870', 'ion', 166, '↓'), ('CHEBI_5893', 'indapamide', 167, 'Ionized'), ('GO_0070481', 'nuclear-transcribed mRNA catabolic process, non-stop decay', 167, 'Ionized'), ('CHEBI_32588', 'potassium chloride', 175, 'Ca'), ('GO_0050892', 'intestinal absorption', 178, 'Intestinal absorption'), ('UBERON_0000160', 'intestine', 178, 'Intestinal'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 238, 'PTHrP'), ('GO_0065007', 'biological regulation', 290, 'regulated'), ('CHEBI_32588', 'potassium chloride', 322, 'Ca'), ('GO_0097578', 'sequestering of copper ion', 335, 'Bone resorption'), ('UBERON_0001088', 'urine', 352, 'Urinary'), ('CHEBI_32588', 'potassium chloride', 360, 'Ca'), ('UBERON_0002450', 'decidua', 427, 'decidua'), ('UBERON_0000310', 'breast', 439, 'breastsNo'), ('UBERON_0001987', 'placenta', 459, 'placental'), ('UBERON_0002331', 'umbilical cord', 529, 'umbilical cord'), ('UBERON_0000922', 'embryo', 548, 'fetal'), ('UBERON_0001132', 'parathyroid gland', 554, 'parathyroid glands'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D'), ('UBERON_0001987', 'placenta', 640, 'placental'), ('PR_000004968', 'calretinin', 729, 'calbindin'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 739, 'D9k'), ('CHEBI_23965', 'estradiol', 799, 'estradiol'), ('CHEBI_81588', 'Placental lactogen', 821, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 821, 'placental lactogen'), ('UBERON_0001987', 'placenta', 821, 'placental'), ('UBERON_0002113', 'kidney', 868, 'kidney'), ('CHEBI_17793', 'calycosin', 875, 'Calcitonin'), ('UBERON_0002046', 'thyroid gland', 906, 'thyroid'), ('UBERON_0001987', 'placenta', 938, 'placental'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 999, 'PTHrP'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1006, 'parathyroid hormone'), ('UBERON_0001132', 'parathyroid gland', 1006, 'parathyroid'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 1026, 'related protein'), ('PR_000004968', 'calretinin', 1043, 'calbindin'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 1053, 'D9k'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin D')]
S170-PMC5084016	PMC5084016	10/2016	S170-PMC5084016	['a systematic review of the literature HIGHLIGHTED an INCREASED RISK of iron and Vitamin B 12 deficiency and low Birth weight in ASSOCIATION with vegetarian or strictly vegan diets, DESPITE the absence of adverse EFFECTS for the fetus [79].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 128), ('ANOMALY_CURIOUS_FINDING', 181), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 80, 'vitamin B 12'), ('GO_0007567', 'parturition', 112, 'birth')]
S162-PMC5118763	PMC5118763	12/2016	S162-PMC5118763	['hemodilution and Placental Transport Of Vitamin B-12 To the Fetus (18) MAY BE POSSIBLE EXPLANATIONS for the OBSERVED decrease in Plasma concentrations of Vitamin B-12.']	[('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 108)]	4	[('GO_0007565', 'female pregnancy', 17, 'placental'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('GO_0042790', 'nucleolar large rRNA transcription by RNA polymerase I', 27, 'transport of vitamin B-12 to'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 40, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 60, 'fetus'), ('UBERON_0001969', 'blood plasma', 129, 'plasma'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin B')]
S108-PMC5133057	PMC5133057	10/2016	S108-PMC5133057	['it is IMPORTANT TO NOTE that EVEN IF the reduction occurs with more intensity in the second and third quarter due to Plasma volume expansion and increased Vitamin A transfer from the mother to the fetus, special ATTENTION throughout Pregnancy is NECESSARY, PARTICULARLY in the first trimester, when the major changes in the Fetal Development occur.']	[('IMPORTANT_CONSIDERATION', 6), ('ANOMALY_CURIOUS_FINDING', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 246), ('IMPORTANT_CONSIDERATION', 257)]	7	[('UBERON_0001969', 'blood plasma', 117, 'plasma'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 324, 'fetal development')]
S100-PMC5167470	PMC5167470	12/2016	S100-PMC5167470	['in this regard, the most FREQUENTLY DESCRIBED maternal Micronutrient deficiency is that of Folic Acid, which entails a high risk of fetal Neural Tube defects.68moreover, there HAVE BEEN case reports of maternal and fetal hypercoagulability due to Vitamin K deficiency following bpd, Ophthalmic and Renal malformations due to SEVERE maternal and fetal Vitamin a deficiency, and megaloblastic anemia due to Vitamin B12 deficiency.69–71\n\nconclusion\nPregnancy after bs is SAFE, both for the mother and for the fetus.']	[('ANOMALY_CURIOUS_FINDING', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 468)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 55, 'micronutrient'), ('CHEBI_30751', 'formic acid', 91, 'folic acid'), ('UBERON_0001049', 'neural tube', 138, 'neural tube'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin K'), ('UBERON_0000970', 'eye', 283, 'ophthalmic'), ('UBERON_0002113', 'kidney', 298, 'renal'), ('CHEBI_33229', 'vitamin (role)', 351, 'vitamin'), ('CHEBI_33279', 'vitamin D5', 405, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 405, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 446, 'Pregnancy')]
S29-PMC5405075	PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
S44-PMC5405075	PMC5405075	4/2017	S44-PMC5405075	['OF NOTE, Food base approaches MAY BE ASSUMED AS a better representative of long-term Vitamin D Intake, which MIGHT INFLUENCE the fetus during all stages of Gestation and EVEN ex utero .']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('ANOMALY_CURIOUS_FINDING', 170)]	8	[('CHEBI_33290', 'food', 9, 'food'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('GO_0007565', 'female pregnancy', 156, 'gestation')]
S15-PMC5418719	PMC5418719	5/2017	S15-PMC5418719	['CONSIDERING the high incidence of Vitamin D deficiency/insufficiency in preterm infants that miss the late Gestation period, which builds Vitamin D stores from mother to fetus, a Vitamin D supply MIGHT be NECESSARY and URGENT to compensate the sufficient Vitamin D level.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 196), ('IMPORTANT_CONSIDERATION', 205), ('IMPORTANT_CONSIDERATION', 219)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'gestation'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
S95-PMC5489519	PMC5489519	6/2017	S95-PMC5489519	['the functional ROLE of Vitamin D in fetus and infant’s Bone Development has been PREVIOUSLY demonstrated.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 81)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0048539', 'bone marrow development', 55, 'bone development')]
S34-PMC5634602	PMC5634602	10/2017	S34-PMC5634602	['the Fetus relies solely on maternal stores for Vitamin D in utero, and TYPICALLY has Cord Blood levels APPROXIMATELY 50–75% of the maternal value [6,27,28].']	[('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 103)]	2	[('UBERON_0000312', 'inner cambium layer of periosteum', 4, 'fetus'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0000178', 'blood', 90, 'blood')]
S107-PMC5664622	PMC5664622	9/2017	S107-PMC5664622	['in OUR STUDY, we FOUND that maternal Vitamin D concentration of >15.3 ng/ml, i.e., half the recommended dose, would be sufficient to meet the DEMANDS of the developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 142)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
S109-PMC5664622	PMC5664622	9/2017	S109-PMC5664622	['DECLARED that maternal Vitamin D concentration which is NECESSARY for the fetus OUGHT to be >20 ng/ml [11].']	[('IMPORTANT_CONSIDERATION', 0), ('IMPORTANT_CONSIDERATION', 0), ('IMPORTANT_CONSIDERATION', 56), ('IMPORTANT_CONSIDERATION', 80)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
S135-PMC5664622	PMC5664622	9/2017	S135-PMC5664622	['in OUR STUDY, we FOUND that the lowest maternal Vitamin D level should be ≥15.3 ng/ml in order to meet the demands of the fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
S156-PMC5706533	PMC5706533	11/2017	S156-PMC5706533	['NONETHELESS, there was no EVIDENCE of any specific harms to mothers or fetuses attributable to Vitamin D supplementation within the range of reported doses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
S78-PMC5838372	PMC5838372	3/2018	S78-PMC5838372	['discussion\nvitamin D deficiency LEADS TO IMPORTANT health PROBLEMS, NOT ONLY in mothers BUT ALSO in their infants, BECAUSE the Vitamin D store of the mother is the MAJOR source of Vitamin D for the fetus (9).']	[('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('ANOMALY_CURIOUS_FINDING', 88), ('PROBABLE_UNDERSTANDING', 115), ('IMPORTANT_CONSIDERATION', 164)]	8	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 19, 'D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
S17-PMC5841533	PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
S661-PMC5941617	PMC5941617	5/2018	S661-PMC5941617	['RECENT STUDIES SUGGEST a RELATIONSHIP between maternal Vitamin D status during Pregnancy and bone mass of the fetus and the newborn.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy')]
S84-PMC6011374	PMC6011374	6/2018	S84-PMC6011374	['ALTHOUGH, a 56% decreased risk for gdm was observed in those with low-moderate levels of standardised Vitamin D when compared to moderate-high levels for women carrying a female fetus (arr: 0.44; 95% ci: 0.20, 0.97).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S107-PMC6011374	PMC6011374	6/2018	S107-PMC6011374	['in THIS STUDY, we observed marginal sex-specific DIFFERENCES between early Pregnancy Vitamin D status and Pregnancy outcome where by high Vitamin D status and carrying a male fetus was moderately ASSOCIATED with decreasing the risk of having any Pregnancy complication.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('SUPERFICIAL_RELATIONSHIP', 196)]	3	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
S108-PMC6011374	PMC6011374	6/2018	S108-PMC6011374	['CONVERSELY, high Vitamin D status and carrying a female fetus was not associated with changing the risk of having any Pregnancy complication.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
S110-PMC6011374	PMC6011374	6/2018	S110-PMC6011374	['this is similar to that which has PREVIOUSLY been shown in the RELATIONSHIP between Vitamin D status at ≤26\xa0weeks’ Gestation and Placental pathology in Pregnancy [51] SUGGESTING that male and female fetuses respond differently to maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 167)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('UBERON_0001987', 'placenta', 129, 'placental'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
